Post by Joséphine Kant

A country's long-term position in AI will not be decided by who wins this week's argument. It will be decided by who builds this decade's companies. Today the UK Sovereign AI Fund is investing in one of them. We are proud to back Isomorphic Labs, the London-headquartered, DeepMind-born AI drug design company led by Sir Demis Hassabis and Max Jaderberg. Our investment is part of Isomorphic's $2.1B Series B led by Thrive Capital, alongside Alphabet, GV (Google Ventures) Tom Hulme, MGX, Temasek and CapitalG. A British-built company committed to solving humanity's hardest problems - here. This is what we were built for.